Patient P-01541
Synthetic patientNBL-101 · Day 115 · 25–34 · M · baseline S09Steering view · 3DOpen companion preview
Therapy response
Stable
Tolerance
Improving
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Favorable
Discontinuation risk
13%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 NBL-101 started — Baseline state S09
- Day 72 AD-05 recommended — Adherence Support AD-05
- Day 73 Patient accepted — Started AD-05 in the companion
- Day 78 No meaningful change — Adherence Support AD-05
- Day 98 Trajectory diverged from prediction — Observed response fell below the model's expected path.
What changed?
Trajectory began diverging from predicted response on Day 98.
Primary contributors, last 14 days
- Toxicity-9
- Inflammatory activity-8
- GI instability-6
- Treatment adherence+2
What helped?
- Adherence Support AD-05Day 72Result: no meaningful change
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
GI burden
Companion18.9/100
worsening · +1.6 vs previous 14 d
Toxicity
Blood9.6/100
worsening · +1.6 vs previous 14 d
Sleep quality
Wearable67.2/100
stable · -0.0 vs previous 14 d
Energy level
Daily log5.9/10
worsening · -0.3 vs previous 14 d
Stress level
Daily log2.8/10
worsening · +0.3 vs previous 14 d
Steps
Wearable3,813
improving · +155 vs previous 14 d
Adherence
Companion86.3 %
stable · -3.3 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →Heading towards restoration · 69 from the failing basin, 35 from restoration.
Good elements to keep
- Butyrate producers intacthidden · steering +7.5
- Insoluble fibre (supports)perturbation · steering +3
- Adherence Support AD-05intervention · steering +2.9
- Insoluble fibresupporter · GI -1.8 next day
Main detractors to watch
- FUT2 non-secretorhidden · steering -10.6
- Histamine loadperturbation · steering -5.9
- Alcoholperturbation · steering -3.7
- Poor-sleep weekperturbation · steering -3
- Histamine loaddetractor · GI +3.6 next day
- Alcoholdetractor · GI +2.3 next day
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Histamine load+3.6detractor · 95%
- Alcohol+2.3detractor · 62%
- Insoluble fibre-1.8supporter · 62%
- Dietary fat load+1.7no signal · 42%
- Spicy / capsaicin-0.5no signal · 15%
- Simple carbohydrates-0.1no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Mucosal barrier integrity ↓30
- DNAFUT2 non-secretor lowers mucosal fucosylation
- Autonomic recovery ↑20
- Wearable3,813 steps/day
DNA
Fictional pharmacogenomic panel
- FUT2 rs601338 AA (non-secretor)Reduced mucosal fucosylation
- CYP2D6 Normal metabolizerExpected exposure
Microbiome
Shannon diversity 4.3 · butyrate capacity 48/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisNormal
- Bifidobacterium longumNormal
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 53 ms
- Sleep
- 8.0 h
- Steps
- 3,195
- Resting HR
- 60 bpm
Daily log: GI score 19, nutritional resilience 61, adherence 86.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- A 15-minute walk after lunch
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.